Ani Sarkis Balmanoukian

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors

  The Oncologist · 2025-05-15 · 3 citations

• First-in-human phase I open-label study of the anti–TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors

  The Oncologist · 2025-05-15 · 18 citations

• Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial

  Nature Medicine · 2025-01-01 · 97 citations

• Palbociclib in Patients With Head and Neck Cancer and Other Tumors With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study

  JCO Precision Oncology · 2024-10-01 · 4 citations